Shah Gaurav plan to sell securities of ROCKET PHARMACEUTICALS, INC. under Form 144

Shah Gaurav filed Form 144 to notify SEC of plan to sell 2728 units of ROCKET PHARMACEUTICALS, INC. securities around 2026-05-13, with aggregate market value of $9,836.08. The total outstanding units is 109193549.0. The amount planned to be sold represents 0.00% of total outstanding units; Recent transactions in past 3 months include: On 02/13/2026, sold 12279 units for $40669.28; On 02/18/2026, sold 5990 units for $19997.62;